Tous Actualités
Suivre
Abonner Jacobson Resonance Enterprises

Jacobson Resonance Enterprises

Jacobson Resonance Enterprise, Inc. Receives Allowance From FDA to "Enhance Feelings of Relaxation" With the Jacobson Resonator

BOYNTON BEACH, FL (ots)

Jacobson Resonance Enterprises, Inc.
(OTC BB: JRSE) announced today that the United States Food and Drug
Administration has granted an allowance to implement our
state-of-the-art Jacobson Resonance Technology in the multi-billion
dollar leisure/spa arena for relaxation purposes. Specifically, JRSE
submitted an application in accordance with Section 513(g) of the
Federal Food, Drug, and Cosmetic Act and was granted an allowance by
the Center for Devices and Radiological Health (CDR1-1) for the
indication designated as to "enhance feelings of relaxation."
Dr. Jerry I. Jacobson, Chairman of the Board, Chief Executive 
Officer and Chief Science and Technology Officer of JRSE 
shares; "After twenty-four years of theorizing I am witnessing a 
dream come true, the reality of a vision. The vision was one of 
hope and love for all humans, for what the future could bring with 
the Unified-Field Equation mc squared = Bvlq. Magnetism may be 
utilized to enhance feelings of relaxation. We use the lowest level 
of magnetic fields non-invasively. The FDA has recognized, in my 
opinion that static magnetic fields are in use all over the world 
for the specific indication of relaxation. We plan now to enter 
into the spa and leisure arenas worldwide including resorts and 
cruise ships. Chiropractors and a variety of healthcare providers 
will also benefit from this technology. The markets are numerous 
and we believe this technology will become widespread for the 
betterment of all mankind."
Harvey Grossman, President and Chief Strategic Officer of JRSE
also shares; "I am both excited and humbled by the potential good for
our shareholders and all humanity this FDA allowance brings. After
many long years of ups and downs like the Cyclone Rollercoaster, JRSE
has endured for one reason and one reason only. The discovery that
Dr. Jacobson made in 1979 has been validated through rigorous science
and an adventurer's spirit. Let us all rejoice in the potential
benefits that this allowance brings and may we all pray for the
guidance necessary to follow the right path for the benefit of all
involved."
Anthony P. Fusco, JR., Vice President and Chief Operating Officer 
of JRSE additionally shares; "In the short time that I have been a 
member of the JRSE team I have witnessed many astonishing and 
enlightening events that can only attest to the origin of the 
Discovery and its purpose to help mankind. Today the light is 
shining on an integral part of the JRSE mosaic. This confirmation 
of our technology in the USA will allow us to implement an 
important aspect of our business model."
Additional news releases in the near future will provide more 
information about the application of this FDA allowance into 
revenue producing projects.
Dr. Jacobson and Mr. Grossman are hosting a JRSE/Magnetic
Resonance Therapy (Bahamas), Limited "Educational & Business
Development Retreat" in New Providence, Nassau, Bahamas from
Thursday, February 26 through Sunday Morning, February 29, 2004. The
purpose of this pivotal gathering is to discern the most correct path
to follow in order to fulfil the often stated mission of this
corporation, the eradication of human suffering while providing a
fair return to our investors. Additionally, both tactical and
strategic plans will be developed in order to expedite the creation
of long-awaited revenues. For further information concerning
attendance at this historical retreat, please call Anthony P. Fusco
JR., international headquarters, Boynton Beach, Florida, USA, at
561.752.4141.
JRSE is an emerging worldwide leader in magnetic resonance 
technology, whose main focus is the eradication of human suffering. 
The Company's technology base has the potential for multiple 
industry applications including the fields of medicine, spa and 
leisure arena, food and beverage, pharmaceuticals, energy and the 
environment.
This press release contains forward-looking statements within the 
meaning of the Private Securities Litigation Reform Act of 1995. 
The matters covered by such forward-looking statements are subject 
to known and unknown risks, uncertainties and other factors which 
may cause actual results, performance or achievements of the 
Company to differ materially from those contemplated or implied by 
such forward-looking statements. Included in these risks and other 
factors are funding availability, competition from better-financed 
companies and required regulatory clearances.
ots Original Text Service: Jacobson Resonance Enterprise, Inc.
Internet: http://www.presseportal.ch
For further information, contact:
Anthony Fusco Jr.
(561) 752.4141